Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

cDNA microarray analysis of vestibular schwannomas.

D Bradley Welling1, John M Lasak, Elena Akhmametyeva

  • 1Department of Otolaryngology, Ohio State University College of Medicine, Ohio, USA. welling.1@osu.edu

Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology
|September 10, 2002
PubMed
Summary

This study identified key genes and pathways involved in vestibular schwannoma development using cDNA microarray analysis. Findings highlight potential therapeutic targets and a deeper understanding of neurofibromatosis type 2 tumor suppressor gene function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of the Surgical Implantation and Fixation of an Implanted Middle Ear Microphone, the "UmboMic," in Cadaveric Sheep.

Journal of the Association for Research in Otolaryngology : JARO·2026
Same author

Characterizing the effects of anti-PD1 immunotherapy on ataxia in a vestibular schwannoma mouse model.

Journal of neuro-oncology·2026
Same author

A plasma metabolomic fingerprint of moderate or severe hearing loss.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss.

Nature communications·2026
Same author

Hearing preservation and restoration surgery in NF2-related schwannomatosis.

Familial cancer·2026
Same author

Hearing loss in the young-old is associated with increased risk for Alzheimer's disease and vascular dementia.

Journal of Alzheimer's disease : JAD·2026

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Vestibular schwannomas are associated with neurofibromatosis type 2 (NF2) gene mutations, but the underlying mechanisms remain unclear.
  • Gene expression profiling offers a method to identify molecular pathways involved in tumor formation.

Purpose of the Study:

  • To compare gene expression profiles in vestibular schwannomas versus normal vestibular nerve tissue.
  • To identify altered molecular pathways implicated in schwannoma tumorigenesis.

Main Methods:

  • cDNA microarray analysis of 25,920 genes using RNA from one normal vestibular nerve and seven schwannomas.
  • Validation of differentially expressed genes using real-time PCR and immunohistochemistry.

Main Results:

Related Experiment Videos

  • Forty-two genes were significantly upregulated (≥3-fold) in at least 5 of 7 tumors, including osteonectin and RhoB GTPase.
  • Downregulated genes included LUCA-15 (apoptosis-related) and ezrin (NF2 protein relative).
  • Real-time PCR and immunohistochemistry confirmed microarray findings.

Conclusions:

  • cDNA microarray analysis revealed potential tumorigenesis pathways in vestibular schwannomas.
  • Further in vivo research is needed to elucidate the roles of identified genes and their connection to the NF2 tumor suppressor gene.